Pathophysiology And Classification

  • Extravasation of erythrocytes into dermis produces non-blanching petechiae and purpura.
  • Etiologies broadly classified into infectious, vasculitic, structural, and hematologic mechanisms.
  • Consumptive coagulopathy and thrombocytopenia directly drive petechial eruptions in multiple systemic disorders.

Vasculitides And Immune-Mediated Disorders

Disease EntityPathophysiology And Clinical FeaturesAnatomical DistributionAssociated Findings
Immunoglobulin A VasculitisImmune-mediated blood vessel inflammation causing palpable nonthrombocytopenic purpuric skin lesions. Immunoglobulin A deposits heavily around vessel walls.Buttocks and gravity-dependent lower extremities.Arthritis, nephritis, abdominal pain, fatigue, and weight loss.
Infantile Hemorrhagic EdemaSudden onset circumscribed edema accompanied by purpuric papules and plaques. Affects primarily infants and toddlers.Trunk, extremities, and commonly face.Strictly lacks extracutaneous organ involvement.
Multisystem Inflammatory Syndrome In ChildrenHyperinflammatory state manifesting with petechiae, purpuric, and retiform lesions.Generalized distribution including hands, feet, face, and perineum.Severe systemic inflammation, multiorgan dysfunction.
Pityriasis Lichenoides Et Varioliformis AcutaAbrupt eruption of numerous 2-3 mm papules developing purpuric centers. Successive crops produce polymorphous appearance.Diffusely distributed on trunk and extremities.Headache, arthralgias, dark adherent hemorrhagic crusts, varioliform scarring.

Infectious Exanthems

  • Infectious etiologies require urgent differentiation from benign purpuric eruptions.
Infectious Agent CategorySpecific Causative Organisms And Features
Bacterial InfectionsMeningococcemia represents critical life-threatening cause of purpuric skin lesions. Rocky Mountain spotted fever induces prominent purpuric rash.
Viral InfectionsEnteroviruses frequently provoke widespread purpuric viral exanthems.

Vascular Tumors And Hematologic Syndromes

Kasabach-Merritt Phenomenon

  • Life-threatening complication of kaposiform hemangioendothelioma.
  • Characterized by rapidly enlarging vascular tumor.
  • Induces severe thrombocytopenia and microangiopathic hemolytic anemia.
  • Triggers acute or chronic consumption coagulopathy.
  • Manifests precipitously with extensive hemorrhage, ecchymoses, and numerous petechiae.
  • Bone marrow reveals increased normal or immature megakaryocytes despite peripheral thrombocytopenia.

Langerhans Cell Histiocytosis

  • Features clusters of infiltrative, crusted, hemorrhagic papules.
  • Systemic involvement induces thrombocytopenia, increasing petechial risk.
  • Favors groin, axillae, periauricular skin, and scalp.
  • Accompanied frequently by hepatosplenomegaly and osseous lesions.

Neonatal Lupus Erythematosus

  • Triggered by transplacental transfer of maternal anti-Ro and anti-La antibodies.
  • Associated with systemic thrombocytopenia, causing petechial manifestations.
  • Often misdiagnosed initially as infantile eczema or tinea corporis.

Connective Tissue And Structural Disorders

Ehlers-Danlos Syndrome

  • Represents inherited vascular fragility syndrome.
  • Structural connective tissue defects predispose to spontaneous petechiae and purpura.

Diagnostic Approach And Management

Clinical EntityDiagnostic ModalityTherapeutic Intervention
Immunoglobulin A VasculitisSkin biopsy demonstrating small vessel vasculitis. Direct immunofluorescence reveals immunoglobulin A in blood vessel walls.Primarily conservative management. Lesions spontaneously resolve within 3-4 weeks.
Infantile Hemorrhagic EdemaClinical morphological assessment distinguishing from true systemic vasculitis.Conservative management.
Infectious PurpuraBlood cultures, specific serologies, lumbar puncture if meningococcemia suspected.Prompt empirical systemic antimicrobial therapy.
Pityriasis LichenoidesSkin biopsy demonstrating epidermal spongiosis and lymphocytic infiltrate.Oral anti-inflammatory antibiotics (erythromycin or doxycycline). Topical corticosteroids.
Kasabach-Merritt PhenomenonClinical evaluation, complete blood count showing profound thrombocytopenia, extensive coagulation profile.Multidisciplinary management targeting underlying kaposiform hemangioendothelioma.